Rafael Marques Porto

Title: Rafael Marques Porto: Innovator in Hybrid Peptide Technology

Introduction

Rafael Marques Porto is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of immunology through his innovative work on hybrid peptides. His research focuses on developing novel solutions for inducing immune responses, particularly in relation to anaplasmosis microorganisms.

Latest Patents

Rafael Marques Porto holds a patent for a hybrid peptide, which includes a set of hybrid peptides, compositions, uses of the hybrid peptide, methods for inducing an immune response, and kits. The invention relates to hybrid peptides developed from the combination of membrane surface protein peptide fragments present in anaplasmosis microorganisms. Each hybrid peptide comprises two or more peptide fragments linked together by a spacer element. The combined peptide fragments include protein peptide fragments of MSP1, MSP1a, MSP1b, MSP2, MSP2-HRV, MSP3, OMP7, OMP8, VirB9, and VirB10. This innovative approach has the potential to enhance immune responses against specific pathogens.

Career Highlights

Throughout his career, Rafael has worked with prominent organizations such as Fundação Butantan and Biotick Pesquisa e Desenvolvimento Tecnológico Ltda. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Rafael has collaborated with talented individuals, including Bárbara Athayde Vaz Galvão Da Silva and Kerly Fernanda Mesquita Pasqualoto. These partnerships have enriched his research endeavors and fostered a collaborative environment for innovation.

Conclusion

Rafael Marques Porto is a distinguished inventor whose work on hybrid peptides is paving the way for advancements in immunology. His contributions are significant in the ongoing fight against infectious diseases.